期刊
JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 136, 期 9, 页码 1755-1759出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2016.05.095
关键词
-
类别
资金
- NCATS NIH HHS [UL1 TR001863] Funding Source: Medline
- NCI NIH HHS [P50 CA121974] Funding Source: Medline
Next-generation sequencing of melanomas has unraveled critical driver genes and genomic abnormalities, mostly defined as occurring at high frequency. In addition, less abundant mutations are present that link melanoma to a set of disorders, commonly called RASopathies. These disorders, which include neurofibromatosis and Noonan and Legius syndromes, harbor germline mutations in various RAS/mitogen-activated protein kinase signaling pathway genes. We highlight shared amino acid substitutions between this set of RASopathy mutations and those observed in large-scale melanoma sequencing data, uncovering a significant overlap. We review the evidence that these mutations activate the RAS/mitogen-activated protein kinase pathway in melanoma and are involved in melanomagenesis. Furthermore, we discuss the observations that two or more RASopathy mutations often co-occur in melanoma and may act synergistically on activating the pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据